This is a paid event, buy tickets here: https://www.economicpolicygroup.com/bioconclave2019india/#tickets

Data, Tech and Patient Centricity in Healthcare and Life Sciences

Taking place in Bangalore, the upcoming bioConclave India 2019 will review the latest industry trends and their potential implications – with focus on Data, Tech and Patient Centricity in Healthcare and Life Sciences.

During this 2-day event, you will hear from patients, pharma/biotech, tech companies and digital health start-up founders about breakthrough innovations, patient engagement, regulations, collaborations and funding.

Both days will include multiple engaging formats: keynotes, talks, interviews, tech discovery, panels, and start-up pitches.

Join the conversation on epg_london via #bioconclave2019 on 21-22 Feb 2019.

About the event

Emerging technologies are rapidly changing the landscape of healthcare & life sciences industry and their relationship with their customers while creating new opportunities for collaboration

Digital and exponential technologies to include AI, cognitive robotics, blockchain health IoT, have the potential individually and cumulatively to transform the business of healthcare and life sciences. From early diagnosis and prevention, to virtual nursing assistants, robotic-assisted surgery, fraud detection, risk and workflow management, no area of clinical and operational business of health will remain untouched. And the potential impact on the life science industry more specifically is equally immense-transforming clinical trial management, lead generation and the current ‘inherently inefficient and costly drug development process’? However, the jury is still out-will these advanced technologies remove costs or ultimately add to costs of the healthcare system?

Featured topics

• Why we should put the patient at the centre of research advances and value driven healthcare?

• The evolving role of technology and data in health research

• How systems of intelligence such as AI can deliver personalised medicine and accelerate the process of clinical trials?

• How systems of engagement can enhance adherence, manage chronic conditions and prevent disease?

• How will AI improve human health?

• What are the potential applications of these technologies, their value and their ability to cut healthcare costs?

• What are the workforce implications? Will these new technologies supplant, complement or augment current healthcare jobs?

• Digital patient and digital biomarker

• What are the regulatory challenges?

Read about bioConclave 2018 in London, here.

For sponsorship and exhibition queries: Smita at spatel@economicpolicygroup.com.

For delegate sales and partnerships: Spoorthy at spoorthy@economicpolicygroup.com